litlas
ログインアカウント作成

T. Scott Stroup

2000–2025 年に発表

79
論文数
24,673
被引用数
67
h 指数
76
i10 指数

被引用数

T. Scott Stroup の年別被引用数1996 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 2 件2001 年: 被引用 2 件2002 年: 被引用 3 件2003 年: 被引用 2 件2004 年: 被引用 12 件2005 年: 被引用 67 件2006 年: 被引用 192 件2007 年: 被引用 310 件2008 年: 被引用 352 件2009 年: 被引用 319 件2010 年: 被引用 359 件2011 年: 被引用 288 件2012 年: 被引用 294 件2013 年: 被引用 206 件2014 年: 被引用 191 件2015 年: 被引用 149 件2016 年: 被引用 162 件2017 年: 被引用 160 件2018 年: 被引用 144 件2019 年: 被引用 522 件2020 年: 被引用 400 件2021 年: 被引用 386 件2022 年: 被引用 274 件2023 年: 被引用 169 件2024 年: 被引用 329 件2025 年: 被引用 103 件2026 年: 被引用 3 件1997〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,081 件、この内訳の 30%イギリス: 引用元論文 713 件、この内訳の 10.3%ドイツ: 引用元論文 388 件、この内訳の 5.6%カナダ: 引用元論文 381 件、この内訳の 5.5%オーストラリア: 引用元論文 293 件、この内訳の 4.2%中国: 引用元論文 276 件、この内訳の 4%イタリア: 引用元論文 240 件、この内訳の 3.5%オランダ: 引用元論文 187 件、この内訳の 2.7%スペイン: 引用元論文 181 件、この内訳の 2.6%日本: 引用元論文 154 件、この内訳の 2.2%スイス: 引用元論文 145 件、この内訳の 2.1%デンマーク: 引用元論文 142 件、この内訳の 2.1%
0%30%その他 25.2%

機関

分野

  • Medicine60.8%
  • Biochemistry, Genetics and Molecular Biology13%
  • Neuroscience10.8%
  • Psychology6.9%
  • Computer Science2.3%
  • Health Professions2%
  • その他4.2%

トピック

  • Schizophrenia research and treatment19.4%
  • Bipolar Disorder and Treatment4%
  • Tryptophan and brain disorders3.6%
  • Mental Health and Psychiatry3.5%
  • Healthcare Decision-Making and Restraints2.6%
  • Treatment of Major Depression2.1%
  • その他64.8%

共著者

全論文

検索で開く
  1. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

    著者: Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, C.E. Davis, Barry D. Lebowitz, Joanne B. Severe, John Hsiao - New England Journal of Medicine 2005 被引用: 5,895

  2. Management of common adverse effects of antipsychotic medications

    著者: T. Scott Stroup, Neil Gray - World Psychiatry 2018 被引用: 558

  3. Premature Mortality Among Adults With Schizophrenia in the United States

    著者: Mark Olfson, Tobias Gerhard, Cecilia Huang, Stephen Crystal, T. Scott Stroup - JAMA Psychiatry 2015 被引用: 1,094

  4. Informing sequential clinical decision-making through reinforcement learning: an empirical study

    著者: Susan M. Shortreed, Eric B. Laber, Daniel J. Lizotte, T. Scott Stroup, Joelle Pineau, Susan A. Murphy - Machine Learning, Mach. Learn. 2010 被引用: 204

  5. Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia

    著者: T. Scott Stroup, Mark Olfson, Cecilia Huang, Melanie M. Wall, Terry E. Goldberg, Davangere P. Devanand, Tobias Gerhard - JAMA Psychiatry 2021 被引用: 111

  6. Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

    著者: Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, Sonia M. Davis, John Hsiao, M. Saleem Ismail, Barry D. Lebowitz, Constantine G. Lyketsos, J. Michael Ryan, T. Scott Stroup, David L. Sultzer, Daniel Weintraub, Jeffrey A. Lieberman - New England Journal of Medicine 2006 被引用: 1,198

  7. Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    著者: Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, Sonia M. Davis, Herbert Y. Meltzer, Robert A. Rosenheck, Marvin S. Swartz, Diana O. Perkins, Richard S.E. Keefe, C.E. Davis, Joanne B. Severe, John Hsiao, for the CATIE Investigators - American Journal of Psychiatry 2006 被引用: 755

  8. Microduplications of 16p11.2 are associated with schizophrenia

    著者: Shane McCarthy, Vladimir Makarov, George Kirov, Anjené Addington, Jon McClellan, Seungtai Yoon, Diana O. Perkins, Diane E. Dickel, Mary Kusenda, Olga Krastoshevsky, Verena Krause, Ravinesh A. Kumar, Detelina Grozeva, Dheeraj Malhotra, Tom Walsh, Elaine H. Zackai, Paige Kaplan, Jaya Ganesh, Ian D. Krantz, Nancy B. Spinner, Patricia Roccanova, Abhishek Bhandari, Kevin Pavon, B. Lakshmi, Anthony Leotta, Jude Kendall, Yoon-ha Lee, Vladimir Vacic, Sydney Gary, Lilia M. Iakoucheva, Timothy J. Crow, Susan L. Christian, Jeffrey A. Lieberman, T. Scott Stroup, Terho Lehtimäki, Kaija Puura, Chad Haldeman‐Englert, Justin Pearl, Meredith Goodell, Virginia L. Willour, Pamela DeRosse, Jo Steele, Layla Kassem, Jessica Wolff, Nisha Chitkara, Francis J. McMahon, Anil K. Malhotra, James B. Potash, Thomas G. Schulze, Markus M. Nöthen, Sven Cichon, Marcella Rietschel, Ellen Leibenluft, Vlad Kustanovich, Clara Lajonchere, James S. Sutcliffe, David Skuse, Michael Gill, Louise Gallagher, Nancy R. Mendell, Nick Craddock, Michael J. Owen, Michael O‘Donovan, Tamim H. Shaikh, Ezra Susser, Lynn E. DeLisi, Patrick F. Sullivan, Curtis K. Deutsch, Judith L. Rapoport, Deborah L. Levy, Mary‐Claire King, Jonathan Sebat - Nature Genetics 2009 被引用: 736

  9. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

    著者: Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff, Henry A. Nasrallah, Sonia M. Davis, Lisa Sullivan, Herbert Y. Meltzer, John Hsiao, T. Scott Stroup, Jeffrey A. Lieberman - Schizophrenia Research 2005 被引用: 1,139

  10. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

    著者: T. Scott Stroup, Joseph P. McEvoy, M S Swartz, Matthew Byerly, Ira D. Glick, José M. Cañive, Michael F. McGee, G. M. Simpson, Michael C. Stevens, Jeffrey A. Lieberman - Schizophrenia Bulletin 2003 被引用: 648

  11. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia

    著者: T. Scott Stroup, Tobias Gerhard, Stephen Crystal, Cecilia Huang, Mark Olfson - American Journal of Psychiatry 2015 被引用: 173

  12. Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

    著者: Hitoshi Sakurai, Robert R. Bies, T. Scott Stroup, Richard S.E. Keefe, Tarek K. Rajji, Takefumi Suzuki, David C. Mamo, Bruce G. Pollock, Koichiro Watanabe, Masaru Mimura, Hiroyuki Uchida - Schizophrenia Bulletin 2012 被引用: 138

  13. Minimum Clinically Important Difference in the Positive and Negative Syndrome Scale With Data From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

    著者: Eric D. A. Hermes, Daniel Sokoloff, T. Scott Stroup, Robert A. Rosenheck - The Journal of Clinical Psychiatry 2012 被引用: 106

  14. Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span

    著者: Mark Olfson, T. Scott Stroup, Cecilia Huang, Melanie M. Wall, Stephen Crystal, Tobias Gerhard - JAMA Psychiatry 2021 被引用: 88

  15. Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

    著者: Jeffrey A. Lieberman, Michael R. Phillips, Hongbin Gu, T. Scott Stroup, Peiyan Zhang, Lan Kong, JI Zhong-fu, Gary G. Koch, Robert M. Hamer - Neuropsychopharmacology 2003 被引用: 345

  16. Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD

    著者: Cheryl Vigen, Wendy J. Mack, Richard S.E. Keefe, Mary Sano, David L. Sultzer, T. Scott Stroup, Karen Dagerman, John Hsiao, Barry D. Lebowitz, Constantine G. Lyketsos, Pierre N. Tariot, Ling Zheng, Lon S. Schneider - American Journal of Psychiatry 2011 被引用: 285

  17. Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder

    著者: L. Fredrik Jarskog, Robert M. Hamer, Diane Catellier, Dawn Stewart, Lisa M. LaVange, Neepa Ray, Lauren H. Golden, Jeffrey A. Lieberman, T. Scott Stroup, for the METS Investigators - American Journal of Psychiatry 2013 被引用: 145

  18. Geographic and Clinical Variation in Clozapine Use in the United States

    著者: T. Scott Stroup, Tobias Gerhard, Stephen Crystal, Cecelia Huang, Mark Olfson - Psychiatric Services 2013 被引用: 128

  19. An international survey examining the impact of the COVID-19 pandemic on telehealth use among mental health professionals

    著者: Madeline I. Montoya, Cary S. Kogan, Tahilia J. Rebello, Karolina Sadowska, José Ángel García‐Pacheco, Brigitte Khoury, Maya Kulygina, Chihiro Matsumoto, Rebeca Robles, Jingjing Huang, Howard Andrews, José Luís Ayuso‐Mateos, Keith Denny, Wolfgang Gäebel, Oye Gureje, Shigenobu Kanba, Karen Maré, María Elena Medina‐Mora, Kathleen M. Pike, Michael C. Roberts, Pratap Sharan, Dan J. Stein, T. Scott Stroup, Min Zhao, Geoffrey M. Reed - Journal of Psychiatric Research 2022 被引用: 44

  20. Relationship of Cognition and Psychopathology to Functional Impairment in Schizophrenia

    著者: Somaia Mohamed, Robert A. Rosenheck, Marvin S. Swartz, T. Scott Stroup, Jeffrey A. Lieberman, Richard S.E. Keefe - American Journal of Psychiatry 2008 被引用: 206

  21. Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia

    著者: Joseph P. McEvoy, Matthew Byerly, Robert M. Hamer, Rosalie Dominik, Marvin S. Swartz, Robert A. Rosenheck, Neepa Ray, J. Steven Lamberti, P.F. Buckley, Tania M Wilkins, T. Scott Stroup - JAMA 2014 被引用: 150

  22. Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States

    著者: Natalie Bareis, Mark Olfson, Melanie M. Wall, T. Scott Stroup - Psychiatric Services 2021 被引用: 45

  23. A National Study of Violent Behavior in Persons With Schizophrenia

    著者: Jeffrey W. Swanson, Marvin S. Swartz, Richard A. Van Dorn, Eric B. Elbogen, Henry R. Wagner, Robert A. Rosenheck, T. Scott Stroup, Joseph P. McEvoy, Jeffrey A. Lieberman - Archives of General Psychiatry 2006 被引用: 804

  24. Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic

    著者: T. Scott Stroup - American Journal of Psychiatry 2006 被引用: 354